Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mayo Clinic
With
National Cancer Institute (NCI)
This Project is designed to identify biologically-based and clinically-useful biomarkers of tissue at risk for neoplastic progression as well as of response to ablation therapy. These results will result in improved risk stratification in BE and better targeting of resources for patients who are candidates for ablative therapy, while simultaneously providing key information regarding the origins of Barrett's esophagus.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Barrett's esophagus with high grade dysplasia or intramucosal (early) adenocarcinoma.
BE length ≥ 2 cm and ≤ 8 cm.
Able to return every 3 months for one year after ablation
You may not be if
Patients who are unable to be compliant with follow-up endoscopies
patients who cannot tolerate Proton Pump inhibitors